DNA topoisomerases as targets for anticancer drugsTOPCU, Z.Journal of clinical pharmacy and therapeutics (Print). 2001, Vol 26, Num 6, pp 405-416, issn 0269-4727Article

Inhibitory activities of Helichrysum taxa on mammalian type I DNA topoisomeraseKUCUKOGLU, O; OZTURK, B; KAMATAKI, T et al.Pharmaceutical biology. 2006, Vol 44, Num 3, pp 189-193, issn 1388-0209, 5 p.Article

The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH : a RING may link hematopoiesis and growth controlTOPCU, Z; MACK, D. L; HROMAS, R. A et al.Oncogene (Basingstoke). 1999, Vol 18, Num 50, pp 7091-7100, issn 0950-9232Article

Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibitionBARAN, Y; ZENCIR, S; CAKIR, Z et al.Journal of clinical pharmacy and therapeutics (Print). 2011, Vol 36, Num 6, pp 673-679, issn 0269-4727, 7 p.Article

RT-PCR-based cytochrome P450 expression profile of oral tissue samplesSARIKAYA, D; CHIBA, I; BILGEN, C et al.Journal of clinical pharmacy and therapeutics (Print). 2007, Vol 32, Num 5, pp 445-448, issn 0269-4727, 4 p.Article